HRB 2024 Evidence review on the distribution, organisation and administration of drug and alcohol services in other European jurisdictions The Health Research Board (HRB) is a research organisation. One of its areas of expertise is alcohol and other drugs, and it holds two national information systems on the topic: the National Drug Related Deaths Index and the National Drug Treatment Reporting System. It also hosts the National Drugs Library, which is an information resource that supports researchers, policy makers, educators, and practitioners who are working to develop the knowledge base around drug, alcohol, and tobacco use in Ireland. The HRB has commissioned nine evidence reviews since 2014 as part of the HRB drug and alcohol evidence review series (see Appendix 1). These reviews are undertaken on behalf of the Drugs Policy Unit in the Department of Health and funding is allocated each year in the national drugs strategy research and monitoring budget for this purpose. These evidence reviews support stakeholders in using research-based knowledge in their decision making, especially regarding their assigned actions under the National Drugs Strategy.
Deadline
The time limit for receipt of tenders was 2024-11-13.
The procurement was published on 2024-10-21.
Contract notice (2024-10-21) Object Scope of the procurement
Title: HRB 2024 Evidence review on Drug and alcohol services
Short description:
“HRB 2024 Evidence review on the distribution, organisation and administration of drug and alcohol services in other European jurisdictions The Health...”
Short description
HRB 2024 Evidence review on the distribution, organisation and administration of drug and alcohol services in other European jurisdictions The Health Research Board (HRB) is a research organisation. One of its areas of expertise is alcohol and other drugs, and it holds two national information systems on the topic: the National Drug Related Deaths Index and the National Drug Treatment Reporting System. It also hosts the National Drugs Library, which is an information resource that supports researchers, policy makers, educators, and practitioners who are working to develop the knowledge base around drug, alcohol, and tobacco use in Ireland. The HRB has commissioned nine evidence reviews since 2014 as part of the HRB drug and alcohol evidence review series (see Appendix 1). These reviews are undertaken on behalf of the Drugs Policy Unit in the Department of Health and funding is allocated each year in the national drugs strategy research and monitoring budget for this purpose. These evidence reviews support stakeholders in using research-based knowledge in their decision making, especially regarding their assigned actions under the National Drugs Strategy.
Show more
Type of contract: Services
Products/services: Social research services📦
Estimated value excluding VAT: 70 000 EUR 💰
Information about lots
Tenders may be submitted for maximum number of lots: 0
Description
Description of the procurement:
“HRB 2024 Evidence review on the distribution, organisation and administration of drug and alcohol services in other European jurisdictions The Health...”
Description of the procurement
HRB 2024 Evidence review on the distribution, organisation and administration of drug and alcohol services in other European jurisdictions The Health Research Board (HRB) is a research organisation. One of its areas of expertise is alcohol and other drugs, and it holds two national information systems on the topic: the National Drug Related Deaths Index and the National Drug Treatment Reporting System. It also hosts the National Drugs Library, which is an information resource that supports researchers, policy makers, educators, and practitioners who are working to develop the knowledge base around drug, alcohol, and tobacco use in Ireland. The HRB has commissioned nine evidence reviews since 2014 as part of the HRB drug and alcohol evidence review series (see Appendix 1). These reviews are undertaken on behalf of the Drugs Policy Unit in the Department of Health and funding is allocated each year in the national drugs strategy research and monitoring budget for this purpose. These evidence reviews support stakeholders in using research-based knowledge in their decision making, especially regarding their assigned actions under the National Drugs Strategy.
Procedure Type of procedure
Open procedure ✅ Administrative information
Time limit for receipt of tenders or requests to participate: 2024-11-13 10:00:00 📅
Conditions for opening of tenders: 2024-11-13 10:30:00 📅
Conditions for opening of tenders (place): https://www.etenders.gov.ie/epps/cft/prepareViewCfTWS.do?resourceId=4520559
Languages in which tenders or requests to participate may be submitted: English 🗣️
Complementary information Review body
Name: The High Court of Ireland
National registration number: The High Court of Ireland
Postal address: Four Courts, Inns Quay, Dublin 7
Postal code: D07 WDX8
Postal town: Dublin
Country: Ireland 🇮🇪
E-mail: highcourtcentraloffice@courts.ie📧
Phone: +353 1 8886000📞 Information about electronic workflows
Electronic invoicing will be accepted
Electronic ordering will be used
Electronic payment will be used
Source: OJS 2024/S 206-639908 (2024-10-21)